4 results
To determine non inferiority of two doses of BI 10773 (10 mg/daily and 25 mg/daily) compared to placebo with respect to first occurrence of any of the adjudicated components of the primary composite Major Adverse Cardiovascular Event endpoint (…
Primary objective:To assess the safety, tolerability and pharmacokinetics of a single IV dosages of OTL-038. Selected doses of OTL-038 will be studied in the absence and presence of prophylactic treatment with the antihistamine clemastine to be…
To evaluate whether doxepin hydrochloride 5% cream is more effective in reducing pruritus in burn patients than standard treatment (clemastine).
1. To adapt and optimize the MR protocol to enable multi-parametric dynamic acquisitions during 1 hour of mild-cold exposure.2. To investigate tissue dynamics of metabolic activity of the hypothalamus, BAT, and skeletal muscles, measured by dynamic…